Decreased monocyte-to-lymphocyte ratio was associated with satisfied outcomes of first-line PD-1 inhibitors plus chemotherapy in stage IIIB-IV non-small cell lung cancer
ObjectivesImmune-checkpoint inhibitors (ICIs) combined with chemotherapy are more widely used than monotherapy and have shown better survival in patients with advanced non-small cell lung cancer (NSCLC) without oncogenic driver alterations. The monocyte-to-lymphocyte ratio (MLR) might predict the tr...
Main Authors: | Liang Zheng, Anning Xiong, Shuyuan Wang, Jianlin Xu, Yinchen Shen, Runbo Zhong, Jun Lu, Tianqing Chu, Wei Zhang, Ying Li, Xiaoxuan Zheng, Baohui Han, Hua Zhong, Wei Nie, Xueyan Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-01-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1094378/full |
Similar Items
-
Impact of BMI on the survival outcomes of non-small cell lung cancer patients treated with immune checkpoint inhibitors: a meta-analysis
by: Tongtong Zhang, et al.
Published: (2023-10-01) -
Rechallenge of immune checkpoint inhibitors in advanced non‐small cell lung cancer
by: Gen Lin, et al.
Published: (2024-02-01) -
Evaluation of Response to Immune Checkpoint Inhibitors Using a Radiomics, Lesion-Level Approach
by: Chorog Song, et al.
Published: (2021-12-01) -
Monocyte to HDL Cholesterol Ratio (MHR) and Monocyte to Lymphocyte Ratio (MLR) in Overweight and Obese Women
by: Novitasari SOESILO, et al.
Published: (2023-12-01) -
Association of metabolomics with PD-1 inhibitor plus chemotherapy outcomes in patients with advanced non-small-cell lung cancer
by: Jun Lu, et al.
Published: (2024-04-01)